Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
At least half the dose leaked out while administering/butneedle used was defective and at least half of the dose leaked out, so patient did not get full dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 05-NOV-2025, the patient received Shingrix. On 05-NOV-2025, an unknown time after receiving Shingrix, the patient experienced accidental underdose (Verbatim: At least half the dose leaked out while administering/butneedle used was defective and at least half of the dose leaked out, so patient did not get full dose.). The outcome of the accidental underdose was not applicable. Additional Information: GSK receipt date:10-NOV-2025, 11-NOV-2025 The reporter was consented to follow up. The batch number was not provided upon follow up with the reporter.